Customer Service

PrevistageTM GCC Colorectal Cancer Staging Test

DiagnoCure has granted an exclusive worldwide license for this test which is now offered by Signal Genetics.

Bladder Cancer Test (formerly ImmunoCyt™/uCyt+™)

Diagnocure entered into a product divestment agreement for ImmunoCyt™/uCyt+™ with U.S.-based Scimedx Corporation.

More on Scimedx